Patient Care Outreach, Navigation, Technology and Support (COUNTS) 2.0
Official title: The Patient Care Outreach, Navigation, Technology and Support 2.0 Study
Run by University of California, San Francisco · NCT06648278 · Data updated 2026-11-12
This project will test a multilingual virtual patient navigation portal to help English-, Chinese-, and Spanish-speaking adults with breast cancer or cardiovascular disease in underserved communities.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Status | Recruiting |
| Started | August 10, 2023 |
| Main results expected | February 28, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT06648278 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) diagnosed with any stage breast cancer or with cardiovascular disease who speak English, Mandarin/Cantonese, or Spanish, are connected to UCSF/ZSFG or partner outreach channels, and have access to a phone that can receive text messages.
✕Probably not a fit
Patients without reliable phone or internet access, those who cannot provide informed consent for medical or psychological reasons, or those who require only in-person navigation may not benefit from this virtual program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
COUNTS 2.0 builds on an existing patient navigation program by expanding an online portal and materials into Chinese and Spanish and testing usability in underserved communities. The team will recruit participants through UCSF clinics, registries, Zuckerberg San Francisco General, and community partners, using focus groups with patients, navigators, caregivers, and social workers to refine culturally specific content. Enrolled participants and family members will use the web portal and receive virtual navigation, complete quality-of-life assessments and surveys, and receive outreach messages over a six-to-seven month follow-up. The study is primarily a feasibility and implementation effort to determine reach, acceptability, and practical barriers to wider rollout.
Why it matters
Potential benefit: If successful, this could expand access to culturally and linguistically appropriate navigation services for underserved patients, improving care coordination and access to resources.
How similar studies have gone: Earlier navigation programs, including the original Patient COUNTS, have shown promise in supporting underserved patients, but fully virtual, multilingual portal implementations remain less tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For Focus groups: * Breast cancer patients: Diagnosed with breast cancer, ages 18 or older, speaks English, Mandarin/Cantonese, or Spanish * Navigators: any patient navigator who has provided care to underserved populations diagnosed with cancer For Portal Implementation phase: * Ages 18 or older * Speaks English, Mandarin/Cantonese, Spanish, * Has any stage breast cancer * Has access to a phone that is able to receive text messages, is willing to stay in the study for six-seven months. Family User experience survey: * Family member or friend who may have assisted breast cancer participant with registration, accessing or otherwise assisting breast cancer family member or friend participant with the online portal. Exclusion Criteria: * Any medical or psychological conditions precluding informed consent
Where it's running
-
Zuckerberg San Francisco General Hospital
San Francisco, California, United States Recruiting -
University of California, San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Scarlett L Gomez, PhD — University of California, San Francisco
- Study coordinator: Laura Allen
- Email: Laura.Allen@ucsf.edu
- Phone: 415-818-7143
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Global Cardio Oncology Registry
This study is collecting health information from cancer patients around the world to see what factors might increase their risk of heart problems caused by cancer treatments.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.